Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not
FDA Law Blog: Biosimilars
FEBRUARY 11, 2024
Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. Rescheduling would eliminate a tax burden on cannabis companies, allowing licensed companies to expand investments into state programs and focus on public health in collaboration with law enforcement efforts.
59 
Let's personalize your content